×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
戻る Agenda
Session 7: Artificial Intelligence (AI) and Machine Learning (ML) Use in Clinical Trials: How Do We Use Artificial Intelligence (AI) and Machine Learning (ML) in Clinical Trials?
Session Chair(s)
Steven Murray, PhD
Group Vice President and Principal Engineer, Electrical and Data Sciences
Exponent, United States
An exploration of the use of advanced analytics for clinical trials. Can these techniques add insight? Will the regulators buy it? We will explore what technical things are possible, and how they can be measured.
Learning Objective : At the conclusion of this session, participants should be able to:
- Understand the regulatory concerns or requirements for using AI and ML in clinical trials
- Grasp the benefits and limitations of using this technology
- Start a thought process about how they might incorporate these technologies into future trials if possible
Speaker(s)
Dynamic Data Monitoring for Ongoing Clinical Trials
Tai Xie, PhD
CIMS Global, United States
Founder and CEO
Speaker
Seleen Ong, MRCP, MSc, FFPM
Pfizer, Inc., United Kingdom
Executive Director Clinical Group Lead
Speaker
Tala Fakhouri, PhD, MPH
FDA, United States
Associate Director for Policy Analysis, Office of Medical Policy, CDER